Velcade Lung Cancer Study Begins

... New Velcade Cancer Study Begins TheStreet.com Street Insight Search For: Quote Content Advanced Search Jim Cramer $Cramer's Blog Cramer's Columns RealMoney Radio Show RealMoney Radio RealMoney Radio Recap RealMoney Radio Mailbag Mad Money TV Show Mad Money Recap Mad Money Lightning Round Mad Money Mailbag Mad Money Performance More Cramer Essentials $Action Alerts PLUS 25 Rules for Investing 10 Commandments of Trading Cramer's Books Cramer Interviews News & Analysis Latest Stories Winners and Losers Analysts' Actions Insight & Advice Technology ETFs Options and Futures Company News Small Business Personal Finance Mutual Funds ETFs Retirement Taxes IRAs The Good Life Streaming Quotes Markets Markets Update Earnings Reports Energy Currencies Bonds Analysts' Actions Economic Calendar Video and Audio StreetWatch Video Cramer Interviews Mutual Funds/ETF Report The Five Dumbest Things on Wall Street Market Updates Options Updates The Good Life Executive Interviews Market Strategy Audio Cramer RealMoney Radio TheStreet University SubscriptionServices Consumer Services Action Alerts PLUS RealMoney Stocks Under $10 Breakout Stocks Internet Review Options Alerts Value Investor TheStreet.com Top Stocks Dividend Stock Advisor Telecom Connection Daily Swing Trade Trading Reports Short Advisor Technology Report Professional Services Street Insight TheStreet View Logout Bloody Nose for NastechTysabri Study Results PublishedErbitux Gets Added Approval TheStreet.com ...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news